CHV.CN - Canada House Wellness Group Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.0750
0.0000 (0.00%)
At close: 3:27PM EDT
Stock chart is not supported by your current browser
Previous Close0.0750
Open0.0750
Bid0.0700 x 0
Ask0.0800 x 0
Day's Range0.0750 - 0.0750
52 Week Range0.0650 - 0.4500
Volume140,500
Avg. Volume153,947
Market Cap18.987M
Beta (3Y Monthly)1.05
PE Ratio (TTM)N/A
EPS (TTM)-0.0570
Earnings DateMar 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Canada House Wellness Group Inc. Builds off Sales License, Executes Convertible Security Funding Agreement

    TORONTO , Sept. 10, 2019 /CNW/ - Canada House Wellness Group Inc. (CHV.CN) ("Canada House" or the "Company"), announced today that it has entered into a funding agreement (the "Funding Agreement" or "Agreement") for the issue of convertible securities for gross proceeds of up to $14,587,500 CAD (the "Investment") with an entity managed by The Lind Partners, a New York -based institutional fund manager (the "Investor"). At the first closing, the Company will issue a convertible security (the "First Convertible Security") to the Investor with a face value of $3,105,000 CAD. "This investment from The Lind Partners is a strong validation of the fundamentals of our business and further accelerates our Path to Profitability," said Chris Churchill-Smith , CEO, Canada House.

  • CNW Group

    Abba Medix Group, a Canada House Wellness wholly owned subsidiary, Secures Amended Sales License from Health Canada

    TORONTO , Sept. 3, 2019 /CNW/ - Canada House Wellness Group Inc. (CHV.CN) ("Canada House" or the "Company"), announced today that its wholly owned subsidiary, Abba Medix Corp. ("Abba"),  has secured its amended sales license from Health Canada which allows for the sale of its own cannabis directly to patients and consumers. With this amendment, Abba plans to sell cannabis, including its own Abba Medix brand, in dried flower format, directly to registered medical patients and authorized provincial/territorial distributors and retailers across Canada. Abba can start legally selling its own branded dry flower on September 18, 2019 , after its 60-day Notice of Intent to Sell expires.  Patients can pre-register on the Abba website (www.abbamedix.com). Abba's 22,000 sq. ft. indoor production facility in Pickering, Ontario , has dried flower packaged and ready for sale.

  • CNW Group

    Canada House Wellness Group Reports Fiscal Year 2019 Results

    Canada House Wellness Group Reports Fiscal Year 2019 Results

  • GlobeNewswire

    Leo Acquisitions and CBx Brands Announce Letter of Intent for Proposed Qualifying Transaction

    Leo Acquisitions Corp. (LEQ-H.V) (“Leo” or the “Company”) and CBx Brands Inc. (“CBx”) are pleased to announce that they have entered into a letter of intent (the “LOI”), dated July 10, 2019, pursuant to which the Company and CBx have agreed to complete a transaction (the “Transaction”) that will result in a reverse take-over of the Company by the shareholders of CBx. It is intended that the Transaction will constitute the "Qualifying Transaction" of the Company as such term is defined in Policy 2.4 of the Corporate Finance Manual (the “Policy”) of the TSX Venture Exchange (the “TSXV”).

  • CNW Group

    Abba Medix Group, a wholly owned subsidiary of Canada House Wellness Group Inc., Provides Update on Amendment to Sales License and Harvest

    TORONTO , July 25, 2019 /CNW/ - Canada House Wellness Group Inc. (CHV.CN) ("Canada House" or the "Company"), announced today that its wholly owned subsidiary, Abba Medix Corp. ("Abba"),  is working closely with Health Canada to amend its existing sales license to allow for the sale of its own cannabis. Once the amendment to its sales license is received, Abba plans to sell cannabis, including its own Abba Medix brand, in dried flower format, directly to registered medical patients and authorized provincial/territorial distributors and retailers across Canada. Abba has also provided to the Minister of Health, a 60-day notice of its intent to sell its packaged cannabis as per the Canadian Cannabis Act regulations. Abba also continues to move forward with further amendments to its sales license for oils and other product formats.

  • CNW Group

    Canada House Wellness Group Inc. Announces Partnership with Weedbox Inc.

    TORONTO , July 15, 2019 /CNW/ - Canada House Wellness Group Inc. (CHV.CN) ("Canada House" or the "Company") today announced it has entered into a binding agreement on July 12, 2019 (the "Agreement") with Weedbox Inc. ("Weedbox"). The Agreement outlines details for the completion and operation of its previously announced licensed Cannabis Dispensary in Edmonton, Alberta (the "Dispensary"). Site plans and construction of the Dispensary under the Weedbox lifestyle brand, Somewhere Variety®, will begin in the fall of 2019 with an anticipated opening in spring 2020.

  • GlobeNewswire

    Canada House Wellness Group Announces Appointment of Michael Orrbrooke as President of Wholly Owned Subsidiary Abba Medix Corp.

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”), is pleased to announce the appointment of Michael Orrbrooke as the President of the Company’s wholly owned Licensed Producer, Abba Medix Corp. (“Abba”), effective immediately.  Mr. Orrbrooke also will continue in his role as the Company’s Chief Revenue Officer. As previously detailed in the Company’s press release dated April 24, 2019, Mr. Orrbrooke has significant experience in various executive roles within the Canadian cannabis industry, both with an early stage applicant and a Tier 2 Licensed Producer. “Mike’s impact on Canada House as Chief Revenue Officer cannot be overstated.

  • GlobeNewswire

    Canada House Wellness Group Inc. Update on Canada House Clinic Expansion

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”), a fully integrated medical cannabis company, is pleased to provide an update on clinic expansion by its wholly owned subsidiary Canada House Clinics Inc. (“CHC”). CHC will open its first clinics in Toronto and Halifax, relocate its Petawawa clinic to a larger space and launch a new clinic model in Edmonton.

  • GlobeNewswire

    Canada House Wellness Group Inc. Announces Additions to Senior Management Team

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”), a fully integrated medical cannabis company, announced today the appointment of two new members of their senior management team, Dr. Lew Pliamm as Medical Director and Liana Del Medico as Director Communications and Investor Relations effective immediately. The Medical Director is a strategic medical advisor across all Canada House divisions.

  • GlobeNewswire

    Canada House Wellness Group Announces First Harvest from its Licensed Facility

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”), a fully integrated medical cannabis company, is pleased to announce that its wholly owned Licensed Producer of pharmaceutical grade cannabis, Abba Medix Corp. (“Abba”), has completed its first commercial scale harvest in its 22,000 sq. ft. production facility, marking an important execution milestone in the Company’s continuous path to profitability. The first plants have now been harvested and are currently drying.  The Company looks forward to bringing its product to market while continuing to ramp up to perpetual production, totalling between 2,000-3,000 kg of dried flower on an annualized basis.

  • GlobeNewswire

    Canada House Wellness Group Signs Lease For Edmonton Dispensary And Receives Major Development Permit From The City of Edmonton

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”), a fully integrated medical cannabis company, announced today that it has signed a lease agreement for its licensed Cannabis Dispensary in Southeast Edmonton, Alberta and received a Major Development Permit to begin construction. According to a recent report by the CBC, Alberta pot smokers are expected to spend about $940 million on legal weed by 2024, with the province becoming Canada's second-largest market for cannabis behind Ontario.

  • GlobeNewswire

    Canada House Wellness Group Announces Appointment of Michael Orrbrooke as Chief Revenue Officer and Issuance of Shares and Stock Options

    Mr. Orrbrooke holds a Bachelors Degree in Business from the University of Guelph and has received Executive Training at Columbia University in New York City. In 2004, he returned to Canada completing strategic assignments in the highly regulated industries of Telecommunications with Bell Canada and Satellite Radio when he helped to launch XM Satellite Radio to the Canadian Marketplace. In 2007, Mr. Orrbrooke acquired a controlling interest in a Specialty Retail Franchise system which he led and grew from 8 stores in the Greater Toronto Area to 21 stores across Canada, at which point he exited through a sale to a strategic buyer.

  • GlobeNewswire

    Canada House Wellness Group Welcomes Gaetan Lussier and Shawn Graham to its Board of Directors

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce the appointment to its Board of Directors of Gaetan Lussier and Shawn Graham. Mr. Lussier was a deputy-minister for 18 years of which 12 years were in Ottawa with Agriculture-Canada and Employment and Immigration. Mr. Lussier has extensive Board experience having sat as a Director on various boards including Shoppers Drug Mart.

  • GlobeNewswire

    Canada House Wellness Group Builds on Sales License, Closes Oversubscribed $3.3 Million Unit Financing

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has closed its financing of units (“Units”) resulting in total gross proceeds to the Company of $3,300,000 (the “Offering”). The Offering was oversubscribed beyond the $3 million maximum Offering initially announced by the Company.

  • GlobeNewswire

    Canada House Oversubscribed in its Unit Financing

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 15, 2019 -- Canada House Wellness Group Inc. (CSE: CHV) (“Canada House”.

  • GlobeNewswire

    Canada House announces its first Toronto clinic in North York’s Champagne Centre to extend its reach to new patients

    Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) is pleased to announce the opening of its first Toronto clinic this Spring at the Champagne Centre, a multidisciplinary medical complex in North York. As a pioneer in cannabinoid therapy clinics, Canada House Clinics (CHC) is expanding to larger centres due to a significant and growing demand amongst key demographics including Boomers and Seniors, in addition to the Veterans historically serviced by its clinics. “Building on our special relationship with Veterans, Canada House is helping all Canadians who are serious about using medical cannabis to improve their health and well-being,” says Chris Churchill-Smith, CEO.

  • GlobeNewswire

    Canada House Wellness Group Inc. builds on Sales License, announces new business structure and the launch of its retail division

    TORONTO, Feb. 20, 2019 -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV), building on its newly awarded Sales License, has announced a major.

  • GlobeNewswire

    Canada House Wellness Group Announces Unit Financing for $2 to $3 Million

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announces that it intends to proceed with a financing of units (“Units”) for total gross proceeds to the Company of $2,000,000 to $3,000,000 (the “Offering”).

  • GlobeNewswire

    Canada House Wellness Group Inc. Accelerates Phenotyping of 62 In-House Genetics

    TORONTO, Feb. 14, 2019 -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) and Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer has.

  • GlobeNewswire

    Canada House Wellness Group Inc. Announces Full Operations in its Facility, Commences Full-Scale Production of EU-GMP Certified Cannabis

    Canada House Wellness Group Inc. (CSE:CHV) (“Canada House”) announced today that Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer, has successfully completed its Pickering, Ont. facility and has commenced full scale operations of the cultivation of pharmaceutical-grade, handcrafted quality cannabis.  This news comes only a few weeks after Abba being awarded its full sales license from Health Canada. As an industry leading fully integrated medical cannabis company providing patient-specific cannabinoid therapy products and services, Canada House looks forward to completing its first full harvest of EU-GMP certified cannabis by July 2019. This production represents annualized projected revenues of between $17m - $25.5m (based on current medical market prices) in addition to the existing $4-5M of revenues forecast from CHV’s clinic division, Canada House Clinics.

  • GlobeNewswire

    Canada House Wellness Group Inc. Appoints Ernst & Young as Auditors

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 08, 2019 -- Canada House Wellness Group Inc. (“Canada House” or the.

  • GlobeNewswire

    Canada House Builds on Sales License with Clinic Expansion in Fredericton

    Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) is pleased to announce the January 21st opening in Fredericton of its eleventh medical cannabis clinic under its wholly owned subsidiary, Canada House Clinics Inc. (“CHC”). CHC is committed to helping many more Canadians improve their physical and mental health with personalized medical cannabis treatment plans.

  • GlobeNewswire

    Canada House Partners with HelloMD to Increase Practitioner Availability and Provide Convenience to Medical Cannabis Patients

    TORONTO, Jan. 10, 2019 -- Canada House Clinics Inc., a division of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House”) and HelloMD, a leading online cannabis telehealth.

  • GlobeNewswire

    Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.

    Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its facility to become EU-GMP compliant by entering into a software licensing agreement (“SaaS Agreement”) with Cannabis OneFive, Inc. The SaaS Agreement provides Abba with the use of C15’s Veeva Quality One unified quality management and document control solution. C15’s leading software is based on its technology partner’s (Veeva Systems, Inc. www.industries.veeva.com) platforms configured, by C15, for the global cannabis industry.

  • GlobeNewswire

    Canada House Announces Further Details of Vegreville Acquisition and Second Tranche of Funding from Alumina Partners

    Last month, Canada House Wellness Group Inc. (“Canada House” or the “Company”) was pleased to announce the acquisition through its wholly owned subsidiary Abba Medix Corp., of all the assets of an Alberta based cannabis production license applicant, including approximately 54 acres of property in the town of Vegreville, Alberta. The purchased assets are the first step in the development of a custom-built production facility to support the Company’s medical and recreational cannabis sales across Western Canada.